Topics

Finance Watch: Cell And Gene Therapies Buck 2019’s Venture Capital Trend

18:35 EST 8 Nov 2019 | SCRIP

Private Company Edition: VC deals are surging this year for cell and gene therapy firms, according to ARM’s third quarter...

      

Related Stories

 

Original Article: Finance Watch: Cell And Gene Therapies Buck 2019’s Venture Capital Trend

NEXT ARTICLE

More From BioPortfolio on "Finance Watch: Cell And Gene Therapies Buck 2019’s Venture Capital Trend"

Quick Search

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...